ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate Nosocomial Transmission of Influenza

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00798421
Recruitment Status : Unknown
Verified November 2008 by University Hospitals, Leicester.
Recruitment status was:  Not yet recruiting
First Posted : November 26, 2008
Last Update Posted : November 26, 2008
Sponsor:
Information provided by:
University Hospitals, Leicester

Brief Summary:

The purpose of this study is to investigate whether influenza can be reliably transmitted from children to susceptible contacts in a health care setting. The goal is to develop a transmission that can then be used to assess interventions to prevent transmission

Research objectives:

To develop a model to investigate the frequency of influenza transmission from an infected child to a susceptible health care worker

Research Hypotheses:

Influenza viruses can be transmitted from infected children to exposed health care workers


Condition or disease
Influenza

Detailed Description:

CHildren with influenza infection presenting to ED will be identified by RAT. Healthy healthcare worker subjects will expose themselves and perform specific activities with the child.

subjects will be followed by diary card, clinical symptom scores and virology swabs to assess frequency of transmission


Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pilot Study to Develop a Model to Evaluate Nosocomial Transmission of Influenza
Study Start Date : December 2008
Estimated Primary Completion Date : April 2009
Estimated Study Completion Date : May 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Flu Flu Shot

Group/Cohort
Heathcare worker
health care worker exposed to patient with influenza



Primary Outcome Measures :
  1. Frequency of transmission of influenza [ Time Frame: 1 weeks ]

Biospecimen Retention:   Samples Without DNA
Throat and nose swabs


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
  1. Healthy subject volunteers > 18 years of age
  2. Children with confirmed influenza presenting to the Children's Hospital, Leicester Royal Infirmary
Criteria

Inclusion criteria:

  • Infected Children

    • Age < 16 years
    • Parents or legal guardians willing to give informed written consent
    • Presenting with a febrile illness confirmed as influenza by near patient rapid antigen testing
  • Healthy volunteers

    • Willing to give informed written consent

Exclusion criteria

  • Children

    • No parents or legal guardians able to give informed consent
  • Healthy volunteers

    • known allergy to oseltamivir or zanamivir
    • presence of underlying condition or concomitant therapy requiring dose alteration of oseltamivir (severe renal or hepatic failure; methotrexate and probenecid)
    • underlying immunosuppressive disorder
    • known galactose intolerance
    • underlying chronic medical condition known to increase risk of influenza-related complications (including asthma, chronic pulmonary airways disease, chronic cardiovascular disease, diabetes mellitus, chronic neurological disorder)
    • inability or contraindication to collection of nasal swabs
    • previous influenza vaccination within 2 years
    • current smoker
    • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00798421


Contacts
Contact: Iain Stephenson, FRCP +44 116 258 6952 iain.stephenson@uhl-tr.nhs.uk

Locations
United Kingdom
University Hospitals Leicester Not yet recruiting
Leicester, Leics, United Kingdom, LE1 5WW
Contact: Iain Stephenson, FRCP    +44 116 2586952    iain.stephenson@uhl-tr.nhs.uk   
Sponsors and Collaborators
University Hospitals, Leicester
Investigators
Principal Investigator: Iain Stephenson, FRCP University Hospitals, Leicester

Responsible Party: Iain Stephenson, University of Leicester, UK
ClinicalTrials.gov Identifier: NCT00798421     History of Changes
Other Study ID Numbers: UHL10421
REC 07/H0402/59
First Posted: November 26, 2008    Key Record Dates
Last Update Posted: November 26, 2008
Last Verified: November 2008

Keywords provided by University Hospitals, Leicester:
Influenza, transmission

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases